Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Henk G. van Eijk is active.

Publication


Featured researches published by Henk G. van Eijk.


Free Radical Biology and Medicine | 1988

Superoxide dependent iron release from ferritin in inflammatory diseases

Pieter Biemond; A. J. G. Swaak; Henk G. van Eijk; Johan F. Koster

Convincing evidence is presented that oxygen free radicals are involved in the pathogenesis of rheumatoid arthritis (RA). Superoxide is produced by polymorphonuclear leucocytes (PMN) in synovial fluid and by macrophages in the synovial membrane. Tissue damage typical for free radical attack is detected in RA. No absolute deficiency of protective factors is found in RA compared to controls, but the available protection is insufficient to cope with all radicals formed. The toxicity of superoxide is increased by iron. It is doubtful whether a low molecular weight iron pool is present. Superoxide is able to release iron from ferritin, providing a suitable source of iron, for the formation of hydroxyl radicals. This new pathogenetic mechanism stimulates to the application of iron chelators in the treatment of RA. Preliminary results with desferrioxamine were disappointing because of serious side-effects. Hopefully in the future intra-articular injection of iron chelators with better pharmacodynamics will be possible. The interaction of free radicals and ferritin is probably also involved in the pathogenesis of other inflammatory diseases such as systemic lupus erythematosus, hepatitis, and haemochromatosus.


Biochemical Pharmacology | 1985

The involvement of iron and lipid peroxidation in the pathogenesis of hcb induced porphyria

M.A. Alleman; Johan F. Koster; J.H.P. Wilson; A. Edixhoven-Bosdijk; R.G. Slee; M.J. Kroos; Henk G. van Eijk

Hexachlorobenzene (HCB) induces a porphyria characterized by a diminished activity of the enzyme uroporphyrinogen decarboxylase (URO-D), presumably due to inactivation by reactive metabolites of HCB. We studied the effect of iron on HCB porphyria in female rats, to determine whether the iron dependent process of lipid peroxidation was involved in the pathogenesis of porphyria. We showed that malondialdehyde formation is increased in rat liver tissue of porphyric rats and that high molecular weight proteins due to cross-linking are formed. We also showed that the induction of porphyria by HCB is dependent on the presence of iron. Our findings suggest that lipid peroxidation is involved in the toxicity of HCB and that the aggravating effects of iron on HCB are mediated by lipid peroxidation.


Biochemical Pharmacology | 1993

The effect of desferrioxamine on iron metabolism and lipid peroxidation in hepatocytes of C57BL/10 mice in experimental uroporphyria

Warry van Gelder; Peter D. Siersema; Arthur Voogd; Nel C.M. de Jeu-Jaspars; Henk G. van Eijk; Johan F. Koster; Felix W.M. de Rooy; J. H. Paul Wilson

The effects of the iron chelator desferrioxamine (DFx) on liver iron accumulation, malondialdehyde (MDA) production, porphyrin accumulation and uroporphyrinogen decarboxylase (URO-D; EC 4.1.1.37) activity were investigated over a period of 14 weeks in C57BL/10 mice, made porphyric by the administration of hexachlorobenzene (HCB) and iron-dextran (Imferon, IMF) or IMF alone. In addition, we measured the amount of low molecular weight (LMW) iron in liver tissue to determine a possible correlation with MDA production. These experiments showed that combined treatment with HCB + IMF, as well as IMF alone, resulted in porphyrin accumulation, increased MDA production and reduced URO-D activity, whereas HCB alone had no effect. DFx caused a reduction in hepatic porphyrins, this reduction being more distinct in the IMF group than in the HCB + IMF group. The effect of DFx on MDA production and URO-D activity was in agreement with the results on porphyrin accumulation. LMW iron pool measurements at 11 weeks correlated well with data on MDA production in all treated groups in that period (r2 = 0.84), suggesting both variables are interdependent. In conclusion, these results suggest an important role for iron in porphyrin accumulation, probably through its catalytic role in the generation of oxygen-related free radicals, resulting in direct damage to URO-D. The effectiveness of DFx in reducing porphyrin accumulation is probably the result of a reduction in LMW iron, thus diminishing the amount of iron available for a catalytic role in the generation of oxygen-related free radicals.


Cell and Tissue Research | 1993

Ferritin accumulation and uroporphyrin crystal formation in hepatocytes of C57BL/10 mice: A time-course study

Peter D. Siersema; Maud I. Cleton-Soeteman; Wim C. de Bruijn; Fiebo J. ten Kate; Henk G. van Eijk; J. H. Paul Wilson

To establish the time-sequence relationship between ferritin accumulation and uroporphyrin crystal formation in livers of C57BL/10 mice, a biochemical, morphological and morphometrical study was performed. Uroporphyria was induced by the intraperitoneal administration of hexachlorobenzene plus iron dextran and of iron dextran alone. Uroporphyrin crystal formation started in hepatocytes of mice treated with hexachlorobenzene plus iron dextran at 2 weeks and in mice treated with iron dextran alone at 9 weeks. In the course of time, uroporphyrin crystals gradually increased in size. Uroporphyrin crystals were initially formed in hepatocytes in the periportal areas of the liver, in which also ferric iron staining was first detected. The amount and the distribution of the main storage form of iron in hepatocytes, ferritin, did not differ between the two treatment groups. Ferritin accumulation preceded the formation of uroporphyrin crystals in hepatocytes in both treatment groups. Moreover, uroporphyrin crystals were nearly always found close to ferritin iron. We conclude that uroporphyrin crystals are only formed in hepatocytes in which also iron (ferritin) accumulates. Hexachlorobenzene accelerates the effects of iron in porphyrin metabolism, but does not influence the accumulation of iron into the liver.


Biometals | 1990

Analysis of iron-containing compounds in different compartments of the rat liver after iron loading

P.L. Ringeling; Natalie Cleton; M.I.E. Huijskes-Heins; Marionne Seip; Wim C. de Bruijn; Henk G. van Eijk

SummaryThe livers of iron-loaded rats were fractionated and a cytosolic fraction, a lysosomal fraction, a siderosomal fraction and haemosiderin were obtained. All iron-containing compounds from these fractions were isolated and their morphology, Fe/P ratios, iron core diameter and peptide content were compared. The cytosolic fraction contained ferritin (CF) and a slower sedimenting, light ferritin (CLF). The lysosomal fraction also contained ferritin (LF) and a slower sedimenting light ferritin (LLF). The siderosomal fraction contained ferritin (SF), a faster sedimenting non-ferritin iron compound (SIC) and haemosiderin (HS). SIC and HS did not resemble ferritin as much as the other products did, but were found to be water-insoluble aggregates. The Fe/P ratios of CF and CLF were lower than the Fe/P ratios of LF and LLF and these in turn had lower Fe/P ratios than SF, SIC and HS. The iron core diameter of the cytosolic ferritin was increased after lysosomal uptake. The iron core diameters of the siderosomal products were smaller. CLF, CF, LF, LLF and SF contained one kind of subunit of approximately 20.5 kDa. SIC and HS contained other peptides in addition to the 20.5-kDa subunit. The results indicate that storage of ferritin molecules is not limited to the cytosolic compartment, but is also the case in the lysosomes. Extensive degradation of the ferritin molecule seems to be confined to the siderosomes.


Biometals | 1989

Lysosomal and cytosolic ferritins A biochemical and electron-spectroscopic study

P.L. Ringeling; Maud I. Cleton; M.J. Kroos; Lianne W. J. Sorber; Wim C. de Bruyn; Pauline M. Harrison; Henk G. van Eijk

SummaryCytosolic and lysosomal ferritin and haemosiderin were isolated from rat livers which had been iron-loaded by four intraperitoneal injections of iron-dextran. The cytosolic and lysosomal ferritins, prepared in a phosphate-free medium, were subjected to gel-filtration chromatography on Sepharose 613, yielding four fractions: a cytosolic monomeric (CMF) and void-volume ferritin fraction (CVVF), and a lysosomal monomeric (LMF) and void-volume ferritin fraction (LVVF). Of each fraction the following aspects were examined: (a) immunoreactivity against specific antiserum; (b) the Fe/P mass ratio and the effect of dialysis on this ratio using electron probe micro-analysis (EPMA); (c) morphology and Fespecific imaging using electron spectroscopic imaging (ESI) and electron energy loss spectroscopy (EELS). For haemosiderin one aspect, the Fe/P ratio, was determined before and after extensive purification. The following results were obtained (a) All ferritin fractions reacted with anti- (rat liver ferritin). (b) The Fe/P ratios as determined in CMF in an haemosiderin were not affected by dialysis or extensive purification, respectively. The Fe/P ratio in CWF was affected by dialysis. In the lysosomal fractions, only a trace of phosphorus (LVVF) or no phosphorus (LMF) was detected. (c) Morphologically, CMF and CVVF were found to be rather homogeneous; the iron core diameters of both fractions were in the known size range. LMF and LVVF were of rather heterogeneous composition; the core diameters of these fractions were different. In conclusion: the phosphorus in ferritin and haemosiderin is firmly bound; Haemosiderin, when derived from ferritin, has to take up phosphorus in the lysosomes.


Placenta | 1992

Regulation of transferrin receptor expression in term human cytotrophoblasts

Marc B. Bierings; Henk G. van Eijk; Miranda R.M. Baert; Hans van Dijk

Summary Placental transferrin receptors (TfRs) located at the apical side of syncytiotrophoblast, mediate placental iron uptake. Changes in TfR density on the maternal-fetal exchange area will immediately affect placental iron uptake. Therefore, this could be a major determinant in the regulation of maternal-fetal iron transport. We have studied mechanisms that might influence TfR expression in cultured human term cytotrophoblasts. These cells are notproliferative in vitro. In many proliferating cell types growth factors, like insulin, cause a redistribution of TfRs from cytosolic pools to the cell surface. Our experiments show that addition of insulin to, or withdrawal of serum from the culture medium does not lead to a change in cell surface TfR levels in term cytotrophoblasts, thus suggesting that the redistribution effect in linked to the mitogenic role of growth factors. Addition of extra iron to the culture medium leads to down-regulation of trophoblast TfR levels. This suggests that Iron-Responsive-Elements, operative in many cell types except in macrophages are involved in the regulation of placental iron uptake. Thus, transplacental iron transport can be protected against iron overload and iron deficiency.


Biochemical Education | 1998

Clinical chemistry in the medical curriculum: From practical to research

Frank J. M. F. Dor; Maud I. Cleton; Gerard de Jong; Henk G. van Eijk

The haemoglobin levels of a group of healthy students aged 18-3(1 years (n = 216) were determined. These were matched with a test population of 34 wind instrument players. The average haemoglobin level of the wind players was significantly higher.


Arthritis & Rheumatism | 1986

Intraarticular ferritin-bound iron in rheumatoid arthritis: A factor that increases oxygen free radical-induced tissue destruction

Pieter Biemond; A. J. G. Swaak; Henk G. van Eijk; Johan F. Koster


Hepatology | 1991

Iron and uroporphyrin in hepatocytes of inbred mice in experimental porphyria: A biochemical and morphological study

Peter D. Siersema; René P. van Helvoirt; D. A. M. Ketelaars; Maud I. Cleton; Wim C. de Bruijn; J. H. Paul Wilson; Henk G. van Eijk

Collaboration


Dive into the Henk G. van Eijk's collaboration.

Top Co-Authors

Avatar

Johan F. Koster

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

M.J. Kroos

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Maud I. Cleton

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Wim C. de Bruijn

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

A. J. G. Swaak

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Hans van Dijk

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

J. H. Paul Wilson

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

P.L. Ringeling

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Peter D. Siersema

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar

Pieter Biemond

Erasmus University Rotterdam

View shared research outputs
Researchain Logo
Decentralizing Knowledge